Scott Gottlieb

CAREER AT THE FOOD AND DRUG ADMINISTRATION

• Dr. Gottlieb focused on a broad range of issues, including drug pricing, medical product innovation, food safety, vaccination, and tobacco and vaping. 
• He advanced new policies to address opioid addiction, working to rationalize prescribing as a way to reduce the rate of a new addiction.
• He helped make the regulatory process for the development and review of novel drug and medical devices more efficient, including the approval of the first gene-therapy-based cancer treatment. 
• He helped advance new frameworks for the modern and safe and effective oversight of gene therapies, cell-based regenerative medicines, targeted drugs, and digital health devices. 
• He presided over a record number of novel drug and medical device approvals in 2017 and then broke that record in 2018.
• He helped promote competition through the approval of a record number of generic drugs, including the creation of new pathways for developing generic copies of complex drugs. 
• He helped advance the FDA’s Oncology Center for Excellence and implement the 21st Century Cures Act to accelerate medical product development.

CAREER AT THE AMERICAN ENTERPRISE INSTITUTE

• Dr. Gottlieb continues his work on improving public health through entrepreneurship and medical innovation.
• He focuses on expanding regulatory approaches to maintain patient and physician autonomy.

HEALTHCARE

• Earlier in his career, Dr. Gottlieb worked as a healthcare analyst for Alex. Brown & Sons. 
• He was a practicing hospitalist and a Clinical Assistant Professor at the New York University School of Medicine. 
• He has worked as a venture capitalist and founder and board member to companies that developed new medicines and advance the delivery of healthcare. 

CURRENT APPOINTMENTS

• Special Partner on the Healthcare Investment Team of New Enterprises Associates
• Resident Fellow at the American Enterprise Institute 
• Elected Member of the National Academy of Medicine
• Member of the Board of Directors at Pfizer

AWARDS AND RECOGNITIONS

• Dr. Gottlieb was recognized by Fortune as one of "The World's 50 Greatest Leaders" in 2018 and 2019.
  
• TIME named him as one of the “50 People Transforming Healthcare.” 

MEDIA AND OTHER APPEARANCES

• In addition to his frequent testimonies before Congress, Dr. Gottlieb is often published and interviewed by the media. 
• His commentary and articles have appeared in various publications and medical journals, including Health Affairs, The Wall Street Journal, The Washington Post, and The New York Times.
  
• His interviews range from Face The Nation, CBS News to Fox News.
• He has held editorial positions on the British Medical Journal and the Journal of the American Medical Association.
• He appears regularly as a commentator on CNBC.